Glycoengineered Acid α-Glucosidase With Improved Efficacy at Correcting the Metabolic Aberrations and Motor Function Deficits in a Mouse Model of Pompe Disease
Yunxiang Zhu(SynZyme Technologies (United States)), Seng H. Cheng(Pfizer (United States)), Ji-Lei Jiang, William M. Canfield(Unknown), Robin J. Ziegler, Timothy Edmunds, Nathan Gumlaw, Jinhua Zhang(Beijing Jiaotong University), Karen Lee(University of Glasgow), Canwen Jiang, Robert J. Mattaliano, Mariko Kudo, Scott D. Bercury(Harvard University)
Cited by 169
Related Papers
Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies
|Oxidative Medicine and Cellular Longevity|2017|685
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
|International Journal of Molecular Sciences|2019|581
Anticoagulant properties of bovine plasma protein C following activation by thrombin
|Biochemistry|1977|491
Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease
|Annals of Neurology|2006|300
Cloning and Expression of Human Core 1 β1,3-Galactosyltransferase
|Journal of Biological Chemistry|2002|291